Skip to main content
. 2011 Aug 22;16(9):1228–1238. doi: 10.1634/theoncologist.2011-0039

Table 1.

Prognostic factors for overall survival (p-value) in first-line metastatic colorectal cancer phase III trials (multivariate analysis)

graphic file with name onc00911-0881-t01.jpg

a Granulocyte count.

b LDH was not introduced in the multivariate analysis despite a strong association in univariate analysis (p < .001).

Abbreviations: -, not specified or not done; Adj therapy, adjuvant therapy; ALP, alkaline phophatase; CEA, carcino-embryonic antigen; LDH, lactate dehydrogenase; No. sites, number of metastatic sites; NS, statistically not significant; PS, performance status; Ref, reference; S, statistically significant; WBC, white blood cell count.